[Revaluation of current antimicrobials. Series 16: Latamoxef sodium].
Kumazawa
J
J
Shinagawa
N
N
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D016106:Methicillin Resistance; D009070:Moxalactam / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D009070:Moxalactam